Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Plasma exchange
4 evidence topics · 4 sources
Guideline recommendation after failure of immunoglobulin and corticosteroids
Pooled randomized evidence for plasma exchange
“Primary outcome measure: one cross‐over trial including 18 participants showed after four weeks, 2 (95% confidence interval (CI) 0.9 to 3.1) points more improvement on an 11‐point disability scale with plasma exchange (10 exchanges over four weeks) than with sham exchange.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Non‐randomised evidence indicates that plasma exchange induces adverse events in 3% to 17% of procedures.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Adverse events related to difficulty with venous access, use of citrate, and haemodynamic changes are not uncommon.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Plasma exchange versus sham exchange: parallel-group trial
“We performed a prospective double-blind trial in which patients with static or worsening disease were randomly assigned to plasma exchange (n = 15) or to sham exchange (n = 14) for three weeks.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“We conclude that for some patients with chronic inflammatory demyelinating polyradiculoneuropathy, plasma exchange has an ameliorating effect on neurologic dysfunction and nerve conduction, but in others no improvement is observed.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Plasma exchange versus sham exchange: double-blind crossover trial
“A primary 'intention to treat' analysis showed significant improvement with PE in all clinical outcome measures: NDS by 38 points, P < 0.001; CG by 1.6 points, P < 0.001; GS by +13 kg, P < 0.003” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“We conclude that PE is a very effective adjuvant therapy for CIDP of both chronic progressive and relapsing course; concurrent immunosuppressive drug treatment is required.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Exchange treatments should be given two to three times per week until improvement is established; the treatment frequency should then be tapered over several months.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote